Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Mar 6, 2023; 11(7): 1528-1548
Published online Mar 6, 2023. doi: 10.12998/wjcc.v11.i7.1528
Table 1 Case characteristics from the current case series
Characteristic
Patient 1
Patient 2
Patient 3
Patient 4
Patient 5
Patient 6
Age in yr635174868092
SexFemaleFemaleMaleFemaleFemaleFemale
ComorbiditiesAH, AsthmaAH, renal transplant, CKD, history of abdominal tumor surgeryAH, IHD, Tonsil carcinoma (status post radiation)AH, COPD, CKDAH, ischemic strokeAH
Chronic anticoagulant/antiplatelet useASANoNoASAASAASA
Clinical presentationat admissionFever, asthenia, myalgiaAsthenia, dyspnea, coughFever, asthenia, loss ofappetiteFever, asthenia, dyspneaFever, asthenia, diarrheaFever, asthenia, dyspnea, cough
Duration of illness before admission in days52011777
SpO2 at admission, %929494788797
Time from admission to bleeding in days92510106
Type of bleedIntraperitonealRSH, Extra-peritonealSRHRSHSRHRSH
Signs and symptoms of bleedAbdominal painLeg edema, asthenia, low hemoglobinAbdominal painAbdominal pain, hypotension, abdominal guardingAbdominal Pain (lateral)Low hemoglobin, abdominal swelling
Hemodynamic instabilityNoNoNoYesNoNo
Maximum O2 therapy prior to bleed15 L, mask3-4 L, mask9 L, mask4 L, mask7 L, nasalOTI
Pulmonary changesModerateSevereMildMildModerateModerate
Length of hospitalization (days)201520112510
Anticoagulation (prophylactic)LMWH 4000 IU, BIDNoLMWH 4000 IU, BIDLMWH 4000 IU, BIDNoLMWH 4000 IU, BID
Anticoagulation (therapeutic)NoLMWH 4000 IU, BIDNoNoLMWH 6000 IU, BIDNo
Antiplatelet therapyASANoASAASANoNo
SteroidsMethyl-prednisoloneMethyl-prednisoloneDexa-methasoneMethyl-prednisoloneMethyl-prednisoloneMethyl-prednisolone
Bioproduct units (pRBC/FFP)2/34/43/22/2NoNo
SurgeryNoYesNoNoYesNo
OutcomeDischargedDischargedDischargedDiedDischargedDied